Oligonucleotides—A Novel Promising Therapeutic Option for IBD

Inflammatory Bowel Diseases (IBD), whose denomination comprehends Crohn's Disease (CD) and Ulcerative Colitis (UC), are intestinal chronic diseases that often require lifelong medical therapy. In the last two decades monoclonal antibodies against the cytokine TNF have become integral parts in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Scarozza, Patrizio, Schmitt, Heike, Monteleone, Giovanni, Neurath, Markus F., Atreya, Raja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491809/
https://www.ncbi.nlm.nih.gov/pubmed/31068803
http://dx.doi.org/10.3389/fphar.2019.00314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491809/
https://www.ncbi.nlm.nih.gov/pubmed/31068803
http://dx.doi.org/10.3389/fphar.2019.00314

Ejemplares similares